Investors Seek GLP-1 Alternatives After Nausea Hurdles
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
This article breaks down the components that feed a Total Return Index, including price changes, dividends, and corporate actions, and explains how they combine to show true performance.
28,383 articlesA new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
New Fed Chair Kevin Warsh signals a sweeping change in Fed communications. Trump backs the move, triggering volatile ...
Sea Limited faced a challenging year with its shares down significantly. A top executive sold a chunk of stock, promp...
January CPI shows inflation cooled a notch but remains elevated, keeping policy expectations in focus and households ...
Markets steadied after the Supreme Court struck down sweeping tariffs, a move largely priced in by investors. Wall St...
Traders are shifting toward a data-driven approach to forex analysis as policy shifts and macro data reshape currency...
Pfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
A nuclear stock down 46% this year may look tempting, but ambition must be balanced with diligence. This guide breaks...
Nvidia just delivered another earnings beat and a bold $80 billion buyback. As AI infrastructure spending accelerates...
Microsoft stock sinking today has investors looking past a single bad headline. This deep-dive explains the drivers b...
The 2026 housing market here is shifting—fast. This guide shares three practical moves you can make today to buy smar...